Sort
30,917 grants matching “tumor microenvironment”
Inhibitors of proâHGF activation overcome resistance to antiâEGFR therapy
$299,972Lidija Klampfer · Protexase Therapeutics, Inc. · R43 · FY2019 · CA
Development of a universal prodrug approach for antibody based therapeutics
$299,967Marija Vrljic · Scalmibio, Inc · R43 · FY2019 · CA
Role of LRP in Astrocytoma Migration
$299,958Isa M Hussaini · University Of Virginia · R01 · FY2007 · NS
Overcoming anti-PD-1 resistance by systemic delivery of an oncolytic adenovirus that targets TGF-beta
$299,956Prem Seth · Multivir, Inc. · R41 · FY2018 · CA
ITK inhibitors as an immunotherapeutic approach to colorectal cancer
$299,949Paul Changelian · Confluence Life Sciences, Llc · R43 · FY2016 · CA
Layered Cellulosic Scaffolds for 3D Tumor Cell Culture
$299,948Paul Sweetnam · Nano Terra, Inc. · N43 · FY2013 · CA
Development of a T cell-targeted TGF-b antagonist that reverses immune suppression in melanoma patients
$299,946Dori A Thomas-Karyat · Synthis Therapeutics, Inc. · R43 · FY2018 · CA
UNFOLDED PROTEIN RESPONSE IN DRUG SENSITIVITY AND RESISTANCE
$299,930Linda M Hendershot · St. Jude Children'S Research Hospital · P01 · FY2008 · CA
Role of PI3Kinase in Tumor Progression and Metastasis
$299,928Judith A. Varner · University Of California, San Diego · R01 · FY2019 · CA
Origins and functions of pancreatic cancer-associated fibroblasts
$299,922Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
An osteolytic stimuli-responsive nanotherapeutic system for bone metastases
$299,900Xuli Wang · University Of Utah · R01 · FY2014 · CA
The Role of CD4+ T Cells in Antitumor Immunity
$299,889Rongfu Wang · Baylor College Of Medicine · R01 · FY2011 · CA
Targeting Transforming Growth Factor-beta in Metastatic Breast Cancer
$299,882Michael Reiss · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2010 · CA
Targeting Transforming Growth Factor-beta in Metastatic Breast Cancer
$299,882Michael Reiss · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2008 · CA
Targeting Transforming Growth Factor-beta in Metastatic Breast Cancer
$299,882Michael Reiss · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2009 · CA
Integrated Nano-Therapeutics to Overcome Tumor Plasticity and Resistance
$299,852Mansoor M. Amiji · Northeastern University · R56 · FY2017 · CA
Targeting Transforming Growth Factor-beta in Metastatic Breast Cancer
$299,802Michael Reiss · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2007 · CA
The Role of HIF-1alpha in Breast Cancer Stem Cell Activity
$299,800Tiffany Nicole Seagroves · University Of Tennessee Health Sci Ctr · R01 · FY2010 · CA
Topic 394 - A versatile radiation-triggered phosphor platform for localized anti-cancer therapy
$299,799Rao Papineni · Pact And Health, Llc · N43 · FY2019 · CA
Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment
$299,787David L Gorden · Vanderbilt University · U01 · FY2011 · CA
Collaborative Research: Integrated Analysis of Mechanical and Biochemical Effects in Breast Tumor Microenvironment
$299,785Gary Luker · Regents Of The University Of Michigan - Ann Arbor · · FY2022 · ENG
Host's Genes that Control Lymphocyte Infiltration of Tumors
$299,776Peter Demant · Roswell Park Cancer Institute Corp · R01 · FY2010 · CA
Topic 375: Novel Diagnostic Imaging Modality for Monitoring Tumor Responses to a Hyperthermia Immunotherapy (Moonshot)
$299,727Thomas E. Ramsay · · N01 · FY2018 · CA
Automation of MicroC3 as a CDx for myeloma therapies
$299,712Chorom Pak · Lynx Biosciences, Llc · R43 · FY2017 · CA
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
$299,690Patricia Yotnda · Baylor College Of Medicine · R01 · FY2014 · CA